Glucocorticoid-induced osteoporosis
Lukert, B.P.; Raisz, L.G.
Rheumatic Diseases Clinics of North America 20(3): 629-650
1994
ISSN/ISBN: 0889-857X PMID: 7984782 Document Number: 426655
Glucocorticoids are important in the management of rheumatic diseases. Bone loss is one of the most devastating side effects of glucocorticoids because they inhibit calcium transport, cause secondary hyperparathyroidism, hypogonadism, and impairment of osteoblast function. Efforts to control these side effects minimize bone loss.
Document emailed within 1 workday
Related Documents
Miki, T.; Okamoto, K. 2014: Glucocorticoid and Bone. Efficacy of active vitamin D on glucocorticoid-induced osteoporosis Clinical Calcium 24(9): 1387-1392Suzuki, Y.; Wakabayashi, T. 2015: Management of osteoporosis associated with rheumatoid arthritis and glucocorticoid-induced osteoporosis Clinical Calcium 25(12): 1825-1834
Yamamoto, M.; Sugimoto, T. 2014: Glucocorticoid and Bone. Beneficial effect of teriparatide on fracture risk as well as bone mineral density in patients with glucocorticoid-induced osteoporosis Clinical Calcium 24(9): 1379-1385
Ohnaka, K.; Takayanagi, R. 2006: Glucocorticoid-induced osteoporosis Nihon Rinsho. Japanese Journal of Clinical Medicine Suppl 2: 87-91
Den Uyl, D.; Bultink, I.E.M.; Lems, W.F. 2011: Glucocorticoid-induced osteoporosis Clinical and Experimental Rheumatology 29(5 Suppl 68: S93-S98
Tanaka, Y. 2006: Prophylaxis of glucocorticoid-induced osteoporosis Clinical Calcium 16(11): 1858-1865
Chiodini, I.; Francucci, C.M.; Scillitani, A. 2008: Densitometry in glucocorticoid-induced osteoporosis Journal of Endocrinological Investigation 31(7 Suppl): 33-37
Tomita, A. 1998: Glucocorticoid-induced osteoporosis--mechanisms and preventions Nihon Rinsho. Japanese Journal of Clinical Medicine 56(6): 1574-1578
Minisola, S.; Scillitani, A.; Romagnoli, E. 2006: Alendronate or alfacalcidol in glucocorticoid-induced osteoporosis New England Journal of Medicine 355(20): 2156-2157; Author Reply 2157
Lidofsky, S.; Smith, J. 2009: Glucocorticoid-induced osteoporosis in inflammatory bowel disease Medicine and Health Rhode Island 92(4): 128-130
Khan, Y.K.; Kalaaji, A.N.; Clarke, B.L. 2008: Glucocorticoid-induced osteoporosis in dermatologic practice: a review Journal of Drugs in Dermatology: Jdd 7(11): 1053-1059
Lombardi, G.; Colarusso, S.; Di Somma, C.; Guerra, E.; Tauchmanova, L.; Colao, A. 2008: The role of growth hormone in glucocorticoid-induced osteoporosis Journal of Endocrinological Investigation 31(7 Suppl): 38-42
Tanaka, I.; Oshima, H. 2004: Recommendations for the diagnosis and treatment of glucocorticoid-induced osteoporosis Nihon Rinsho. Japanese Journal of Clinical Medicine 62(Suppl 2): 663-667
Tanaka, I.; Oshima, H. 2007: Vitamin K2 as a potential therapeutic agent for glucocorticoid-induced osteoporosis Clinical Calcium 17(11): 1738-1744
Masaki, H.; Miki, T. 2006: Biochemical markers of bone in steroid (glucocorticoid)-induced osteoporosis (GIOP) Clinical Calcium 16(11): 1823-1832
Tałałaj, M.; Gradowska, L.; Marcinowska-Suchowierska, E.; Durlik, M.; Gaciong, Z.; Lao, M. 1996: Efficiency of preventive treatment of glucocorticoid-induced osteoporosis with 25-hydroxyvitamin D3 and calcium in kidney transplant patients Transplantation Proceedings 28(6): 3485-3487
Benucci, M.; Dolenti, S.; Saviola, G.; Manfredi, M. 2006: Modifications of markers of bone resorption in patients affected by glucocorticoid induced osteoporosis (GIOP) treated with neridronate Recenti Progressi in Medicina 97(1): 24-27
Lange, U.; Illgner, U.; Teichmann, J.; Schleenbecker, H. 2004: Skeletal benefit after one year of risedronate therapy in patients with rheumatoid arthritis and glucocorticoid-induced osteoporosis: a prospective study International Journal of Clinical Pharmacology Research 24(2-3): 33-38
Freehill, A.K.; Lenke, L.G. 1999: Severe kyphosis secondary to glucocorticoid-induced osteoporosis in a young adult with Cushing's disease. A case report and literature review Spine 24(2): 189-193
Robin, J.C.; Sirianni, S.R.; Pragay, D.A.; Ambrus, J.L. 1981: Studies on osteoporosis. V. Comparison of methods of evaluation of osteoporosis and study of chromosome changes induced by neutron activation Journal of Medicine 12(4): 251-256